IL17A and pulmonary tuberculosis: This hypothesis could explain why BCG vaccination, which induces strong IFN-γ, but far weaker IL-17A, responses (Fig. 2) (49), has demonstrable protection against disseminated Mtb infection in infants and children but less so against primary pulmonary TB.